Showing results (251-260 of 381) with videos related to
Sort By:
Pageof 39
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 2023
In vivo editing of the pan-endothelium by immunity evading simian adenoviral vectorReka Lorincz, Aluet Borrego Alvarez, Christopher J Walkey, et al.International Journal of Oncology|October 4, 2006
Survivin promoter-based conditionally replicative adenoviruses target cholangiocarcinomaZeng Bian Zhu, Yabing Chen, Sharmila K Makhija, et al.Pulmonary Pharmacology & Therapeutics|March 22, 2005
Selective rat lung endothelial targeting with a new set of monoclonal antibodies to angiotensin I-converting enzymeIrina V Balyasnikova, Roman Metzger, David J Visintine, et al.Gynecologic Oncology|October 18, 2005
Ovarian cancer targeted adenoviral-mediated mda-7/IL-24 gene therapyParameshwar J Mahasreshti, Manjula Kataram, Hongju Wu, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|April 19, 2021
Advanced genetic engineering to achieve in vivo targeting of adenovirus utilizing camelid single domain antibodyMyungeun Lee, Zhi Hong Lu, Charles B Shoemaker, et al.Journal of Ovarian Research|February 16, 2019
Defining a murine ovarian cancer model for the evaluation of conditionally-replicative adenovirus (CRAd) virotherapy agentsRebeca González-Pastor, Ahmad Mohammad Ashshi, Adel Galal El-Shemi, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|April 4, 2006
Triple-targeted oncolytic adenoviruses featuring the cox2 promoter, E1A transcomplementation, and serotype chimerism for enhanced selectivity for ovarian cancer cellsGerd J Bauerschmitz, Kilian Guse, Anna Kanerva, et al.Plos One|December 22, 2017
Adenovirus platform enhances transduction efficiency of human mesenchymal stem cells: An opportunity for cellular carriers of targeted TRAIL-based TR3 biologics in ovarian cancerLindsay M Kuroki, Xingjian Jin, Igor P Dmitriev, et al.Journal of Molecular Biology|July 1, 2009
Structure and uncoating of immature adenovirusAna J Pérez-Berná, Roberto Marabini, Sjors H W Scheres, et al.Cancer Biology & Therapy|January 29, 2010
OSU-03012 enhances Ad.7-induced GBM cell killing via ER stress and autophagy and by decreasing expression of mitochondrial protective proteinsHossein A Hamed, Adly Yacoub, Margaret A Park, et al.Pageof 39